Storytelling of Medical Product Opportunity that Triggered Action from the C-suite
Storytelling of Medical Product Opportunity that Triggered Action from the C-suite
The Situation
Moderna, then pre-IPO – now a leader in mRNA technology for drug discovery – wanted to better
understand the competitive landscape and patient journey of people with seven specific disease states.
Moderna was referred to Sciencia because of our deep scientific knowledge acuity but more importantly,
they knew our reputation of working hard and fast without sacrificing quality and they needed this
project completed quickly. With no time to waste, we worked closely with the Head of Strategy at each
step to ensure we were moving in the right direction. In less than 4 weeks, we needed to perform the
analysis, develop a presentation, and deliver the final presentation to the C-suite.
The Situation
Moderna, then pre-IPO – now a leader in mRNA technology for drug discovery – wanted to better
understand the competitive landscape and patient journey of people with seven specific disease states.
Moderna was referred to Sciencia because of our deep scientific knowledge acuity but more importantly,
they knew our reputation of working hard and fast without sacrificing quality and they needed this
project completed quickly. With no time to waste, we worked closely with the Head of Strategy at each
step to ensure we were moving in the right direction. In less than 4 weeks, we needed to perform the
analysis, develop a presentation, and deliver the final presentation to the C-suite.
The Plan
To start, our team reviewed the internal scientific data
and published materials of the disease areas to
understand the pathologies in more detail.
Specifically, we needed to understand the mechanism
of action of these diseases and associated biomarkers,
to understand their role, if any, in normal physiology
versus pathologies. We continued to look into
competition – including a pipeline analysis – to gain a
high-level overview of the asset mechanism of action
and the likelihood of approval and adoption in the
clinic. Conducting desk research and physician
interviews, we strived to understand the patient
journey of people with the disease, while documenting
the presentation and diagnosis, treatment paradigm
and long-term care, and health outcomes.
The Plan
To start, our team reviewed the internal scientific data
and published materials of the disease areas to
understand the pathologies in more detail.
Specifically, we needed to understand the mechanism
of action of these diseases and associated biomarkers,
to understand their role, if any, in normal physiology
versus pathologies. We continued to look into
competition – including a pipeline analysis – to gain a
high-level overview of the asset mechanism of action
and the likelihood of approval and adoption in the
clinic. Conducting desk research and physician
interviews, we strived to understand the patient
journey of people with the disease, while documenting
the presentation and diagnosis, treatment paradigm
and long-term care, and health outcomes.
The Result
After synthesizing all the research materials and
patient journey map, we transformed the data
into a visual story to help our audience – busy
C-suite executives – quickly understand the
market landscape and clinical adoption risk of
each disease state. In just under 4 weeks,
working closely with the internal team, we
researched the landscape, performed interviews
and delivered a visual and scientifically accurate
presentation that allowed their team to
immediately grasp the situation. From there,
they made decisions to push forward internal
programs, positioning themselves for success in
the market.
The Result
After synthesizing all the research materials and
patient journey map, we transformed the data
into a visual story to help our audience – busy
C-suite executives – quickly understand the
market landscape and clinical adoption risk of
each disease state. In just under 4 weeks,
working closely with the internal team, we
researched the landscape, performed interviews
and delivered a visual and scientifically accurate
presentation that allowed their team to
immediately grasp the situation. From there,
they made decisions to push forward internal
programs, positioning themselves for success in
the market.
“Sciencia was a great partner. The project was time sensitive,
complex, and required frequent communication and they delivered
on all dimensions. We were very pleased with the final product
and look forward to working together in the future.”
Evan Rachlin, MD
Head of Strategy
Head of Strategy
“Sciencia was a great partner. The project was time sensitive,
complex, and required frequent communication and they delivered
on all dimensions. We were very pleased with the final product
and look forward to working together in the future.”
Evan Rachlin, MD
Head of Strategy
Head of Strategy
Ready to discover product positioning insights
through journey mapping? </span
Ready to discover product positioning insights through journey mapping? </span
[oceanwp_library id="4017"]
[oceanwp_library id="3033"]
[oceanwp_library id="4224"]
